W. Dewilde

发表

Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.

P. Harst, M. Voskuil, P. van der Harst, 2021, International journal of cardiology.

How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018

W. Dewilde, J. T. ten Berg, A. de Veer, 2020, Netherlands Heart Journal.

Correlation of FFR-derived from CT and stress perfusion CMR with invasive FFR in intermediate-grade coronary artery stenosis

J. Leipsic, P. Dendale, W. Dewilde, 2018, The International Journal of Cardiovascular Imaging.

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.

M. Postma, P. van der Harst, F. Asselbergs, 2019, The New England journal of medicine.

‘Ins’ and ‘outs’ of triple therapy

J. M. Berg, F. Verheugt, W. Dewilde, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials

G. Lip, B. Mahmoodi, W. Dewilde, 2017, Circulation.

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Tom Adriaenssens, J. Herrman, F. Verheugt, 2013, The Lancet.

Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta‐analysis

A. Colombo, F. D’Ascenzo, W. Dewilde, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Optimal antithrombotic treatment in patients with atrial fibrillation and coronary stents: an update

W. Dewilde, J. T. ten Berg, N. Bennaghmouch, 2016, Current opinion in cardiology.

The effect of acenocoumarol on the antiplatelet effect of clopidogrel

T. Bergmeijer, W. Dewilde, J. T. ten Berg, 2015, Thrombosis and Haemostasis.

Triple therapy for atrial fibrillation and percutaneous coronary intervention

W. Dewilde, J. T. ten Berg, N. Bennaghmouch, 2015, Current opinion in cardiology.

Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.

J. DiNicolantonio, S. Bangalore, F. Gaita, 2015, The American journal of cardiology.

Reply: Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yet.

F. Verheugt, M. Lamberts, W. Dewilde, 2015, Journal of the American College of Cardiology.

Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial.

C. V. van Mieghem, J. Vos, F. Verheugt, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Atrial fibrillation and coronary artery disease: which antithrombotic treatment strategy?

M. Lamberts, W. Dewilde, M. L. Hansen, 2014, Current opinion in cardiology.

Antiplatelet therapy and anticoagulants – Authors' reply

F. Verheugt, W. Dewilde, J. Berg, 2013, The Lancet.

Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).

W. Dewilde, J. Berg, 2009, American heart journal.

Symptomatic arrhythmogenic right ventricular dysplasia/cardiomyopathy. A two-centre retrospective study of 15 symptomatic ARVD/C cases and focus on the diagnostic value of MRI in symptomatic ARVD/C patients

W. Dewilde, E. Wever, Y. Vandekerckhove, 2008, Acta Cardiologica.

Early double stent thrombosis associated with clopidogrel hyporesponsivenesss

W. Dewilde, D. Kerkhof, L. M. Rademakers, 2011, Netherlands Heart Journal.

Diagnostic performance of quantitative coronary computed tomography angiography and quantitative coronary angiography to predict hemodynamic significance of intermediate-grade stenoses

P. Dendale, W. Dewilde, P. Vanhoenacker, 2015, The International Journal of Cardiovascular Imaging.

RENOVASCULAR HYPERTENSION ASSOCIATED WITH NEUROFIBROMATOSIS: A CASE REPORT

W. Dewilde, L. Missault, A. Bol, 2007, Acta clinica Belgica.

ArtIcle ‘Ins’ and ‘outs’ of triple therapy Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary

F. Verheugt, W. Dewilde, N. Breet, 2010 .

A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention

W. Dewilde, N. Bennaghmouch, J. M. Berg, 2022 .

The WOEST 2 registry

W. Dewilde, A. de Veer, N. Bennaghmouch, 2022, Netherlands Heart Journal.

Triple therapy: the future or from the past?

W. Dewilde, J. T. ten Berg, N. Breet, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.

S. Windecker, M. Valgimigli, P. Smits, 2022, Journal of the American College of Cardiology.

Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.

C. V. van Mieghem, M. Meuwissen, J. Herrman, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.

A. Íñiguez, S. Windecker, M. Valgimigli, 2022, Journal of the American College of Cardiology.

Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype

P. van der Harst, F. Asselbergs, B. Mahmoodi, 2021, Circulation. Cardiovascular interventions.

Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry.

J. Brachmann, A. Erglis, W. Dewilde, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Triple therapy: triple safety or triple danger?

W. Dewilde, J. T. ten Berg, N. Breet, 2010, The American journal of cardiology.

Unifocal Right-Sided Ablation Treatment for Neurally Mediated Syncope and Functional Sinus Node Dysfunction Under Computed Tomographic Guidance

W. Wijns, W. Dewilde, Filip Charlier, 2018, Circulation. Arrhythmia and electrophysiology.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Triple Therapy: Triple Safety or Triple Danger? We read the report by Zinn and Feit 1

W. Dewilde, J. Berg, N. Breet, 2010 .

Triple antithrombotic management after stent implantation: when and how?

W. Dewilde, J. Berg, 2009, Heart.

Semi-Quantitative Versus Visual Analysis of Adenosine Perfusion Magnetic Resonance Imaging in Intermediate-Grade Coronary Artery Stenosis Using Fractional Flow Reserve as the Reference: A Pilot Study

P. Dendale, W. Dewilde, J. Dacher, 2022, Journal of the Belgian Society of Radiology.

Semi-quantitative Analysis of Adenosine Perfusion Magnetic Resonance Imaging Outperforms Visual Analysis in Identifying Fractional Flow Reserve-Altered Intermediate-grade Coronary Artery Stenosis: A Pilot Study

P. Dendale, W. Dewilde, J. Dacher, 2021 .

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†

W. Desmet, J. Wykrzykowska, V. Ntziachristos, 2015, European heart journal.

Cardiac surgery in a patient with essential thrombocythemia: a case report

H. Endeman, W. Dewilde, J. M. Berg, 2010, Netherlands Heart Journal.

Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis.

Deepak L. Bhatt, L. Fauchier, C. Cannon, 2020, Thrombosis research.

Dual Antiplatelet Therapy in the Anticoagulated Patient Undergoing Percutaneous Coronary Intervention Risks, Benefits, and Unanswered Questions

W. Dewilde, N. Bennaghmouch, J. Berg, 2014, Current Cardiology Reports.

Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review.

F. Verheugt, M. Lamberts, W. Dewilde, 2014, Journal of the American College of Cardiology.

Optimal antiplatelet and anticoagulant therapy in patients with oral anticoagulation in coronary stenting

W. Dewilde, 2014 .

An acute posterior myocardial infarction complicated with late pseudoaneurysm of the posterior wall.

W. Dewilde, J. Delanote, L. Muyldermans, 2006, International journal of cardiology.

Antiplatelet Therapy in Patients with Atrial Fibrillation: A Systematic Review and Metaanalysis of Randomized Trials.

J. Healey, S. Connolly, J. Eikelboom, 2021, European heart journal. Cardiovascular pharmacotherapy.

A clinical risk score to identify patients at high risk of very late stent thrombosis

J. Wykrzykowska, M. Gimbel, T. Bergmeijer, 2018, Journal of interventional cardiology.

An anomalous right coronary artery originating from the mid portion of the left descending artery.

W. Dewilde, J. T. ten Berg, B. Scholzel, 2009, International journal of cardiology.

CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.

M. Postma, F. Asselbergs, A. de Boer, 2014, American heart journal.

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

M. Postma, P. van der Harst, F. Asselbergs, 2021, American Journal of Cardiovascular Drugs.

Value of Relative Myocardial Perfusion at MRI for Fractional Flow Reserve-Defined Ischemia: A Pilot Study.

A. de Roos, P. Dendale, W. Dewilde, 2019, AJR. American journal of roentgenology.

Right pulmonary vein and biatrial compression by a massive descending aorta aneurysm.

J. Voigt, J. Ector, W. Dewilde, 2007, International journal of cardiology.

The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries.

G. Lip, S. Windecker, K. Huber, 2012, Journal of interventional cardiology.

Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients: Rationale and Design of the LEGACY study.

P. Damman, P. Woudstra, J. Jukema, 2023, American heart journal.

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, Lancet.

Author reply: The importance of basic cardiology.

W. Desmet, W. Dewilde, 2008, International journal of cardiology.